product summary
Loading...
company name :
R&D Systems
product type :
protein
product name :
Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF
catalog :
3485-AN-050
quantity :
50 ug
price :
458 USD
more info or order :
citations: 6
Reference
Hefni E, Menon D, Ma T, Asiedu E, Sultan A, Meiller T, et al. Angiopoietin-like 4 induces head and neck squamous cell carcinoma cell migration through the NRP1/ABL1/PXN pathway. Cell Signal. 2023;108:110697 pubmed publisher
van der Kolk B, Vink R, Jocken J, Roumans N, Goossens G, Mariman E, et al. Effect of diet-induced weight loss on angiopoietin-like protein 4 and adipose tissue lipid metabolism in overweight and obese humans. Physiol Rep. 2018;6:e13735 pubmed publisher
Gruppen E, Kersten S, Dullaart R. Plasma angiopoietin-like 4 is related to phospholipid transfer protein activity in diabetic and non-diabetic subjects: role of enhanced low grade inflammation. Lipids Health Dis. 2018;17:60 pubmed publisher
Baba K, Kitajima Y, Miyake S, Nakamura J, Wakiyama K, Sato H, et al. Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines. Sci Rep. 2017;7:11127 pubmed publisher
Alex S, Lange K, Amolo T, Grinstead J, Haakonsson A, Szalowska E, et al. Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ. Mol Cell Biol. 2013;33:1303-16 pubmed publisher
Kersten S, Lichtenstein L, Steenbergen E, Mudde K, Hendriks H, Hesselink M, et al. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol. 2009;29:969-74 pubmed publisher
product information
brand :
R&D Systems, a Bio-Techne Brand
catalog number base :
3485-AN
SKU :
3485-AN-050
product name :
Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF
Description :
The Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF from R&D Systems is derived from NS0. The Recombinant Human Angiopoietin-like 4 C-Terminal Frag, CF has been validated for the following applications: Inhibition Activity.
target :
Angiopoietin-like Protein 4/ANGPTL4
category :
Proteins and Enzymes
unit size :
50 ug
buffer :
Lyophilized from a 0.2 µm filtered solution in Tris-Citrate and NaCl.
conjugate :
Unconjugated
purity :
>90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
species :
Human
observed molecular weight :
36 kDa, reducing conditions
theoretical molecular weight :
28 kDa
gene symbol :
ANGPTL4
details of functionality :
Measured by its binding ability in a functional ELISA. When Recombinant Human Angiopoietin-like 4/ANGPTL4 C-Terminal Fragment is immobilized at 1 µg/mL, 100 µL/well, the concentration of Recombinant Human LILRB2/CD85d/ILT4 Fc Chimera (Catalog # 2078-T4 ) binds with an ED50 of 70.0-350 ng/mL.
endotoxin note :
<1.0 EU per 1 µg of the protein by the LAL method.
accessionNumbers :
Q9BY76
applications :
Inhibition Activity
source :
NS0-derived Recombinant Human Angiopoietin-like 4 C-Terminal Frag
USD :
458 USD
alt names :
Angiopoietin like Protein 4, angiopoietin-like 4, Angiopoietin-like protein 4, ANGPTL4, ARP4fasting-induced adipose factor, FIAF, FIAFhepatic angiopoietin-related protein, Hepatic fibrinogen/angiopoietin-related protein, HFARP, HFARPANGPTL2, NL2, peroxisome proliferator-activated receptor (PPAR) gamma inducedangiopoietin-related protein, PGAR, PGARangiopoietin-related protein 4, pp1158, PPARG angiopoietin related protein
storage :
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
more info or order :
company information
R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com
800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.